AXGN vs. ATRO
AXGN (AxoGen, Inc.) and ATRO (Astronics Corporation) are both stocks. AXGN operates in Medical Devices (Healthcare), while ATRO operates in Aerospace & Defense (Industrials). Over the past 10 years, AXGN returned 21.87%/yr vs 13.83%/yr for ATRO. At a 0.09 correlation, their price movements are largely independent.
Performance
AXGN vs. ATRO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AXGN achieves a 37.34% return, which is significantly lower than ATRO's 89.08% return. Over the past 10 years, AXGN has outperformed ATRO with an annualized return of 21.87%, while ATRO has yielded a comparatively lower 13.83% annualized return.
AXGN
- 1D
- 0.25%
- 1M
- 9.90%
- YTD
- 37.34%
- 6M
- 37.29%
- 1Y
- 361.97%
- 3Y*
- 71.00%
- 5Y*
- 15.47%
- 10Y*
- 21.87%
ATRO
- 1D
- 1.60%
- 1M
- 26.83%
- YTD
- 89.08%
- 6M
- 84.09%
- 1Y
- 210.12%
- 3Y*
- 77.18%
- 5Y*
- 41.67%
- 10Y*
- 13.83%
AXGN vs. ATRO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AXGN AxoGen, Inc. | 37.34% | 98.60% | 141.29% | -31.56% | 6.51% | -47.65% | 0.06% | -12.43% | -27.81% | 214.44% |
ATRO Astronics Corporation | 89.08% | 239.85% | -8.38% | 69.13% | -14.17% | -9.30% | -52.67% | -8.21% | -13.21% | 22.55% |
Correlation
The correlation between AXGN and ATRO is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Mar 27, 1990 | 0.09 |
The correlation between AXGN and ATRO shifts across timeframes, from 0.06 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
AXGN:
$2.32B
ATRO:
$3.13B
AXGN:
-$0.66
ATRO:
$1.22
AXGN:
8.97
ATRO:
3.43
AXGN:
9.47
ATRO:
19.35
AXGN:
$238.11M
ATRO:
$886.81M
AXGN:
$178.61M
ATRO:
$272.44M
AXGN:
$5.69M
ATRO:
$74.47M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AXGN vs. ATRO — Risk / Return Rank
AXGN
ATRO
AXGN vs. ATRO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AxoGen, Inc. (AXGN) and Astronics Corporation (ATRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AXGN | ATRO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.02 | ||
| Sortino ratioReturn per unit of downside risk | +2.09 | ||
| Omega ratioGain probability vs. loss probability | 1.76 | 1.53 | +0.23 |
| Calmar ratioReturn relative to maximum drawdown | 18.90 | 9.04 | +9.85 |
| Martin ratioReturn relative to average drawdown | 65.69 | 31.21 | +34.48 |
Loading charts...
Drawdowns
AXGN vs. ATRO - Drawdown Comparison
The maximum AXGN drawdown since its inception was -98.49%, which is greater than ATRO's maximum drawdown of -90.12%. Use the drawdown chart below to compare losses from any high point for AXGN and ATRO.
Loading charts...
Drawdown Indicators
| AXGN | ATRO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.49% | -90.12% | -8.37% |
Max Drawdown (1Y)Largest decline over 1 year | -19.30% | -23.39% | +4.09% |
Max Drawdown (3Y)Largest decline over 3 years | -61.02% | -34.89% | -26.13% |
Max Drawdown (5Y)Largest decline over 5 years | -83.69% | -60.47% | -23.22% |
Max Drawdown (10Y)Largest decline over 10 years | -93.54% | -85.52% | -8.02% |
Current DrawdownCurrent decline from peak | -19.59% | 0.00% | -19.59% |
Average DrawdownAverage peak-to-trough decline | -64.83% | -38.06% | -26.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.54% | 6.76% | -1.22% |
Volatility
AXGN vs. ATRO - Volatility Comparison
The current volatility for AxoGen, Inc. (AXGN) is 11.38%, while Astronics Corporation (ATRO) has a volatility of 19.02%. This indicates that AXGN experiences smaller price fluctuations and is considered to be less risky than ATRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AXGN | ATRO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.38% | 19.02% | -7.64% |
Volatility (6M)Calculated over the trailing 6-month period | 33.36% | 39.42% | -6.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.70% | 55.91% | -2.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.07% | 55.12% | +8.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 62.09% | 56.92% | +5.17% |
Dividends
AXGN vs. ATRO - Dividend Comparison
Neither AXGN nor ATRO has paid dividends to shareholders.
Financials
AXGN vs. ATRO - Financials Comparison
This section allows you to compare key financial metrics between AxoGen, Inc. and Astronics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AXGN vs. ATRO - Profitability Comparison
AXGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AxoGen, Inc. reported a gross profit of 46.19M and revenue of 61.46M. Therefore, the gross margin over that period was 75.2%.
ATRO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Astronics Corporation reported a gross profit of 75.13M and revenue of 230.62M. Therefore, the gross margin over that period was 32.6%.
AXGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AxoGen, Inc. reported an operating income of -2.83M and revenue of 61.46M, resulting in an operating margin of -4.6%.
ATRO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Astronics Corporation reported an operating income of 27.23M and revenue of 230.62M, resulting in an operating margin of 11.8%.
AXGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AxoGen, Inc. reported a net income of -19.58M and revenue of 61.46M, resulting in a net margin of -31.9%.
ATRO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Astronics Corporation reported a net income of 25.54M and revenue of 230.62M, resulting in a net margin of 11.1%.
Frequently Asked Questions
AXGN and ATRO have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATRO has higher volatility (19.02%) compared to AXGN (11.38%). In terms of maximum drawdown, AXGN dropped -98.49% vs ATRO's -90.12%.
AXGN currently has the higher Sharpe Ratio (6.81 vs 3.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AXGN and ATRO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer